NCT05963217
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Relapsed or Refractory CD19+ B-cell Lymphoma
Explore clinical trials studying Relapsed or Refractory CD19+ B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study